{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:35:17Z","timestamp":1792154117862,"version":"4.4.0"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Veterinary Journal"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.tvjl.2015.06.010","type":"journal-article","created":{"date-parts":[[2015,6,14]],"date-time":"2015-06-14T09:42:59Z","timestamp":1434274979000},"page":"38-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Antiviral agents against equid alphaherpesviruses: Current status and perspectives"],"prefix":"10.1016","volume":"207","author":[{"given":"Mar\u00eda A.","family":"Vissani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Thiry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana","family":"Dal Pozzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Barrandeguy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tvjl.2015.06.010_bib0010","first-page":"868","article-title":"Equine coital exanthema","volume":"vol. 2","author":"Allen","year":"2004"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0015","first-page":"829","article-title":"Equid herpesvirus 1 and Equid herpesvirus 4 infections","volume":"vol. 2","author":"Allen","year":"2004"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0020","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.antiviral.2009.11.007","article-title":"Characterization of a thymidine kinase-deficient mutant of equine herpesvirus 4 and in vitro susceptibility of the virus to antiviral agents","volume":"85","author":"Azab","year":"2010","journal-title":"Antiviral Research"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0025","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.tvjl.2011.01.016","article-title":"Equine coital exanthema and its potential economic implications for the equine industry","volume":"191","author":"Barrandeguy","year":"2012","journal-title":"The Veterinary Journal"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0030","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.2042-3292.2002.tb00156.x","article-title":"High case-rate equine herpesvirus 1 abortion outbreak in vaccinated polo mares in Argentina","volume":"14","author":"Barrandeguy","year":"2002","journal-title":"Equine Veterinary Education"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0035","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.theriogenology.2010.03.014","article-title":"Subclinical infection and periodic shedding of equid herpesvirus 3","volume":"74","author":"Barrandeguy","year":"2010","journal-title":"Theriogenology"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0040","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.vetmic.2012.06.024","article-title":"Experimental infection with Equid herpesvirus 3 in seronegative and seropositive mares","volume":"160","author":"Barrandeguy","year":"2012","journal-title":"Veterinary Microbiology"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0045","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1939-1676.2006.tb02901.x","article-title":"Pharmacokinetics of acyclovir after single intravenous and oral administration to adult horses","volume":"20","author":"Bentz","year":"2006","journal-title":"Journal of Veterinary Internal Medicine"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0050","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/jvp.12029","article-title":"Pharmacokinetics of ganciclovir and valganciclovir in the adult horse","volume":"36","author":"Carmichael","year":"2013","journal-title":"Veterinary Pharmacology and Therapeutics"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0055","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1093\/jac\/dkq198","article-title":"ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2","volume":"65","author":"Chono","year":"2010","journal-title":"The Journal of Antimicrobial Chemotherapy"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0060","first-page":"447","article-title":"Antiviral agents","volume":"vol. 1","author":"Coen","year":"2007"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0065","first-page":"2773","article-title":"Varicella-zoster virus. Replication, pathogenesis, and management","volume":"vol. 2","author":"Cohen","year":"2007"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0070","first-page":"18","article-title":"Clinical study evaluating a purified mycobacterial cell wall extract for the treatment of equine respiratory disease","volume":"13","author":"Cormack","year":"1991","journal-title":"Equine Practice"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0075","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/nm0402-386","article-title":"Herpes simplex virus helicase-primase inhibitors are active in animal models of human disease","volume":"8","author":"Crute","year":"2002","journal-title":"Nature Medicine"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0080","series-title":"The use of acyclovir in the treatment of coital exanthema and ocular disease caused by equine herpesvirus 3","author":"Cullinane","year":"1994"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0085","doi-asserted-by":"crossref","first-page":"791","DOI":"10.20506\/rst.33.3.2318","article-title":"Antiviral chemotherapy in veterinary medicine: Current applications and perspectives","volume":"33","author":"Dal Pozzo","year":"2014","journal-title":"Scientific and Technical Review, International Office of Epizootics"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0090","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.vetmic.2010.02.014","article-title":"Herpesvirus systematics","volume":"143","author":"Davison","year":"2010","journal-title":"Veterinary Microbiology"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0095","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00705-008-0278-4","article-title":"The order Herpesvirales","volume":"154","author":"Davison","year":"2009","journal-title":"Archives of Virology"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0100","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1128\/CMR.10.4.674","article-title":"In search of a selective antiviral chemotherapy","volume":"10","author":"De Clercq","year":"1997","journal-title":"Clinical Microbiology Reviews"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0105","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrd703","article-title":"Strategies in the design of antiviral drugs","volume":"1","author":"De Clercq","year":"2002","journal-title":"Nature Reviews Drug Discovery"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0110","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jcv.2004.02.009","article-title":"Antiviral drugs in current clinical use","volume":"30","author":"De Clercq","year":"2004","journal-title":"Journal of Clinical Virology"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0115","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1016\/j.bcp.2004.07.039","article-title":"Discovery and development of BVDU (brivudin) as a therapeutic for the treatment of herpes zoster","volume":"68","author":"De Clercq","year":"2004","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0120","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2217\/17460794.3.4.393","article-title":"Antivirals: Current state of art","volume":"3","author":"De Clercq","year":"2008","journal-title":"Future Virology"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0125","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0166-3542(92)90007-R","article-title":"The acyclic nucleoside analogue penciclovir is a potent inhibitor of equine herpes virus type 1 (EHV-1) in tissue culture and in a murine model","volume":"18","author":"De La Fuente","year":"1992","journal-title":"Antiviral Research"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0130","series-title":"Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine","author":"Elion","year":"1977"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0135","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1099\/0022-1317-79-9-2083","article-title":"Herpesviral thymidine kinases: Laxity and resistance by design","volume":"79","author":"Evans","year":"1998","journal-title":"The Journal of General Virology"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0140","first-page":"703","article-title":"Prevention and control of viral diseases","volume":"vol. 1","author":"Flint","year":"2004"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0145","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2460\/ajvr.69.2.289","article-title":"Effect of topical ophthalmic application of cidofovir on experimentally induced primary ocular feline herpesvirus-1 infection in cats","volume":"69","author":"Fontenelle","year":"2008","journal-title":"American Journal of Veterinary Research"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0150","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1939-1676.2000.tb02236.x","article-title":"Ataxia and paresis with equine herpesvirus type 1 infection in a herd of riding school horses","volume":"14","author":"Friday","year":"2000","journal-title":"Journal of Veterinary Internal Medicine\/American College of Veterinary Internal Medicine"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0155","series-title":"Pahrmacokinetics and clinical efficacy of acyclovir in the treatment of equine herpesvirus type 1 infections","author":"Garre","year":"2008"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0160","doi-asserted-by":"crossref","first-page":"4308","DOI":"10.1128\/AAC.00116-07","article-title":"Pharmacokinetics of acyclovir after intravenous infusion of acyclovir and after oral administration of acyclovir and its prodrug valacyclovir in healthy adult horses","volume":"51","author":"Garre","year":"2007","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0165","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.vetmic.2007.01.004","article-title":"In vitro susceptibility of six isolates of equine herpesvirus 1 to acyclovir, ganciclovir, cidofovir, adefovir, PMEDAP and foscarnet","volume":"122","author":"Garre","year":"2007","journal-title":"Veterinary Microbiology"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0170","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2885.2008.01025.x","article-title":"Multiple oral dosing of valacyclovir in horses and ponies","volume":"32","author":"Garre","year":"2008","journal-title":"Journal of Veterinary Pharmacology and Therapeutics"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0175","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.vetmic.2008.09.062","article-title":"Evaluation of orally administered valacyclovir in experimentally EHV-1-infected ponies","volume":"135","author":"Garre","year":"2009","journal-title":"Veterinary Microbiology"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0180","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.antiviral.2011.11.016","article-title":"Evaluation of the antiviral activity of (1\u2032S,2\u2032R)-9-[[1\u2032,2\u2032-bis(hydroxymethyl)-cycloprop-1\u2032-yl]methyl]x guanine (A-5021) against equine herpesvirus type 1 in cell monolayers and equine nasal mucosal explants","volume":"93","author":"Glorieux","year":"2012","journal-title":"Antiviral Research"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0185","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1128\/CVI.05522-11","article-title":"Immunological correlates of vaccination and infection for equine herpesvirus 1","volume":"19","author":"Goodman","year":"2012","journal-title":"Clinical and Vaccine Immunology"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0190","doi-asserted-by":"crossref","first-page":"147","DOI":"10.21825\/vdt.87264","article-title":"Description of an unusually large outbreak of nervous system disorders caused by equine herpesvirus 1 (EHV-1) in 2009 in Belgium","volume":"80","author":"Gryspeerdt","year":"2011","journal-title":"Vlaams Diergeneeskundig Tijdschrift"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0195","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1939-1676.2007.tb02942.x","article-title":"Outbreak of neurologic disease caused by equine herpesvirus-1 at a university equestrian center","volume":"21","author":"Henninger","year":"2007","journal-title":"Journal of Veterinary Internal Medicine\/American College of Veterinary Internal Medicine"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0200","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1177\/1098612X13489208","article-title":"ABCD: Update of the 2009 guidelines on prevention and management of feline infectious diseases","volume":"15","author":"Horzinek","year":"2013","journal-title":"Journal of Feline Medicine and Surgery"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0205","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1128\/AAC.29.1.171","article-title":"Acyclic guanosine analogs as substrates for varicella-zoster virus thymidine kinase","volume":"29","author":"Karlstrom","year":"1986","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0210","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1126\/science.145.3632.585","article-title":"Therapeutic antiviral action of 5-trifluoromethyl-2\u2032-deoxyuridine in herpes simplex keratitis","volume":"145","author":"Kaufman","year":"1964","journal-title":"Science"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0215","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nm0402-392","article-title":"New helicase-primase inhibitors as drug candidates for the treatment of herpes simplex disease","volume":"8","author":"Kleymann","year":"2002","journal-title":"Nature Medicine"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0220","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.2042-3306.2012.00604.x","article-title":"Third International Havemeyer Workshop on Equine Herpesvirus Type 1","volume":"44","author":"Kydd","year":"2012","journal-title":"Equine Veterinary Journal"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0225","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1939-1676.2009.0304.x","article-title":"Equine herpesvirus-1 consensus statement","volume":"23","author":"Lunn","year":"2009","journal-title":"Journal of Veterinary Internal Medicine"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0230","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.vetmic.2013.06.018","article-title":"Equine herpesviruses type 1 (EHV-1) and 4 (EHV-4) \u2013 masters of co-evolution and a constant threat to equids and beyond","volume":"167","author":"Ma","year":"2013","journal-title":"Veterinary Microbiology"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0235","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.cvsm.2010.07.010","article-title":"Antiviral therapy for feline herpesvirus infections","volume":"40","author":"Maggs","year":"2010","journal-title":"Veterinary Clinics of North America: Small Animal Practice"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0240","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jfms.2008.11.012","article-title":"Treatment of feline herpesvirus-1 associated disease in cats with famciclovir and related drugs","volume":"11","author":"Malik","year":"2009","journal-title":"Journal of Feline Medicine and Surgery"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0245","series-title":"Efficacy of valacyclovir against clinical disease after EHV-1 challenge in aged mares","first-page":"198","author":"Maxwell","year":"2008"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0250","series-title":"Efficacy of valacyclovir against disease following EHV-1 challenge","first-page":"176","author":"Maxwell","year":"2009"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0255","series-title":"Efficacy of delayed antiviral therapy against EHV-1 challenge","author":"Maxwell","year":"2011"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0260","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1939-1676.1998.tb00494.x","article-title":"Neonatal equine herpesvirus type 1 infection on a thoroughbred breeding farm","volume":"12","author":"Murray","year":"1998","journal-title":"Journal of Veterinary Internal Medicine\/American College of Veterinary Internal Medicine"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0265","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.2460\/ajvr.1997.58.10.1141","article-title":"Effects of valacyclovir in cats infected with feline herpesvirus 1","volume":"58","author":"Nasisse","year":"1997","journal-title":"American Journal of Veterinary Research"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0270","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0166-3542(00)00144-3","article-title":"Anti-herpesvirus activity of (1\u2032S,2\u2032R)-9-[[1\u2032,2\u2032-bis(hydroxymethyl)-cycloprop-1\u2032-yl]methyl] x guanine (A-5021) in vitro and in vivo","volume":"49","author":"Neyts","year":"2001","journal-title":"Antiviral Research"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0275","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1128\/JVI.80.8.4047-4060.2006","article-title":"Analysis of equid herpesvirus 1 strain variation reveals a point mutation of the DNA polymerase strongly associated with neuropathogenic versus nonneuropathogenic disease outbreaks","volume":"80","author":"Nugent","year":"2006","journal-title":"Journal of Virology"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0280","series-title":"Equine herpesvirus 1: Role of vaccination","first-page":"14","author":"Osterrieder","year":"2007"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0285","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1365-2885.1996.tb00087.x","article-title":"Pharmacokinetics of acyclovir in the cat","volume":"19","author":"Owens","year":"1996","journal-title":"Journal of Veterinary Pharmacology and Therapeutics"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vetimm.2013.01.010","article-title":"A systematic review of the immune-modulators Parapoxvirus ovis and Propionibacterium acnes for the prevention of respiratory disease and other infections in the horse","volume":"153","author":"Paillot","year":"2013","journal-title":"Veterinary Immunology and Immunopathology"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0295","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.tvjl.2004.04.018","article-title":"Equine herpesviruses 1 (EHV-1) and 4 (EHV-4) \u2013 epidemiology, disease and immunoprophylaxis: A brief review","volume":"170","author":"Patel","year":"2005","journal-title":"The Veterinary Journal"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0300","first-page":"2479","article-title":"The family: Herpesviridae a brief introduction","volume":"vol. 2","author":"Pellet","year":"2007"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0305","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.2042-3306.2010.00307.x","article-title":"Relationship between equine herpesvirus-1 myeloencephalopathy and viral genotype","volume":"42","author":"Pronost","year":"2010","journal-title":"Equine Veterinary Journal"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0310","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.vetmic.2010.03.031","article-title":"Neuropathogenic and non-neuropathogenic variants of equine herpesvirus 1 in France","volume":"145","author":"Pronost","year":"2010","journal-title":"Veterinary Microbiology"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0315","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0006-3002(59)90597-9","article-title":"Synthesis and biological activities of iododeoxyuridine, an analog of thymidine","volume":"32","author":"Prusoff","year":"1959","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0320","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.cveq.2014.08.006","article-title":"Equine Herpesvirus 1 Myeloencephalopathy","volume":"30","author":"Pusterla","year":"2014","journal-title":"Veterinary Clinics of North America Equine Practice"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0325","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.4065\/mcp.2011.0309","article-title":"Antiviral drugs for viruses other than human immunodeficiency virus","volume":"86","author":"Razonable","year":"2011","journal-title":"Mayo Clinic Proceedings"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0330","first-page":"2502","article-title":"Herpes simplex virus","volume":"vol. 2","author":"Roizman","year":"2007"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0335","first-page":"134","article-title":"Equine herpesviruses","volume":"vol. 1","author":"Slater","year":"2007"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0340","series-title":"Equine Infectious Diseases","first-page":"151","article-title":"Equine herpesviruses","author":"Slater","year":"2014"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0345","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.vetmic.2009.07.030","article-title":"The increased prevalence of neuropathogenic strains of EHV-1 in equine abortions","volume":"141","author":"Smith","year":"2010","journal-title":"Veterinary Microbiology"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0350","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.2460\/ajvr.1983.44.06.1032","article-title":"Sensitivity of equine herpesviruses 1 and 3 in vitro to a new nucleoside analogue, 9-[[2-hydroxy-1-(hydroxymethyl) ethoxy] methyl] guanine","volume":"44","author":"Smith","year":"1983","journal-title":"American Journal of Veterinary Research"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0355","series-title":"Antiviral Agents","first-page":"47","article-title":"Nucleotide prodrugs for the treatment of HCV infection","author":"Sofia","year":"2013"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0360","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1177\/135965350701200616","article-title":"Potent inhibition of genital herpesvirus infection in goats by cidofovir","volume":"12","author":"Tempesta","year":"2007","journal-title":"Antiviral Therapy"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0365","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1128\/AAC.00725-08","article-title":"Assessing the efficacy of cidofovir against herpesvirus-induced genital lesions in goats using different therapeutic regimens","volume":"52","author":"Tempesta","year":"2008","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0370","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jfms.2009.05.003","article-title":"Feline herpesvirus infection. ABCD guidelines on prevention and management","volume":"11","author":"Thiry","year":"2009","journal-title":"Journal of Feline Medicine and Surgery"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0375","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2460\/ajvr.72.1.85","article-title":"Evaluation of orally administered famciclovir in cats experimentally infected with feline herpesvirus type-1","volume":"72","author":"Thomasy","year":"2011","journal-title":"American Journal of Veterinary Research"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0380","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/jvim.12051","article-title":"Case-control study of a multistate equine herpesvirus myeloencephalopathy outbreak","volume":"27","author":"Traub-Dargatz","year":"2013","journal-title":"Journal of Veterinary Internal Medicine\/American College of Veterinary Internal Medicine"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0385","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1292\/jvms.09-0350","article-title":"Pharmacokinetics of penciclovir after oral administration of its prodrug famciclovir to horses","volume":"72","author":"Tsujimura","year":"2010","journal-title":"The Journal of Veterinary Medical Science\/The Japanese Society of Veterinary Science"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0390","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.vetmic.2009.06.025","article-title":"Neuropathogenic and non-neuropathogenic genotypes of Equid Herpesvirus type 1 in Argentina","volume":"139","author":"Vissani","year":"2009","journal-title":"Veterinary Microbiology"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0395","series-title":"Effect of acyclovir, ganciclovir and cidofovir on equid herpesvirus 3 in vitro","first-page":"S78","author":"Vissani","year":"2012"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0400","series-title":"Acyclovir as Treatment for EHV-1 Myeloencephalopathy","first-page":"394","author":"Wilkins","year":"2003"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0405","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1476-4431.2005.00145.x","article-title":"Pharmacokinetics of acyclovir in adult horses","volume":"15","author":"Wilkins","year":"2005","journal-title":"Journal of Veterinary Emergency and Critical Care"},{"key":"10.1016\/j.tvjl.2015.06.010_bib0410","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1136\/vr.157.9.254","article-title":"Efficacy of topical aciclovir for the treatment of feline herpetic keratitis: Results of a prospective clinical trial and data from in vitro investigations","volume":"157","author":"Williams","year":"2005","journal-title":"Veterinary Record"}],"container-title":["The Veterinary Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090023315002543?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090023315002543?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T16:32:08Z","timestamp":1748449928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090023315002543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":81,"alternative-id":["S1090023315002543"],"URL":"https:\/\/doi.org\/10.1016\/j.tvjl.2015.06.010","relation":{},"ISSN":["1090-0233"],"issn-type":[{"value":"1090-0233","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiviral agents against equid alphaherpesviruses: Current status and perspectives","name":"articletitle","label":"Article Title"},{"value":"The Veterinary Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tvjl.2015.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}